Back to search

The possible role of iron in the etiopathology of parkinson's disease

Data up to Jan 2025

Published1993
Citations303
References109

Total Citations Per Year

Abstract

References (109)

Free radicals in biology and medicine

1991 • 17,840 citations

Free radicals in biology and medicine

1985 • 2,999 citations

Mitochondrial Complex I Deficiency in Parkinson's Disease

1990 • 2,147 citations

Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts

1986 • 2,052 citations

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

1989 • 1,369 citations

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1989 • 1,367 citations

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1985 • 1,236 citations

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1988 • 1,235 citations

Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

1989 • 1,117 citations

Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease

1989 • 913 citations

The Generation of Hydrogen Peroxide, Superoxide Radical, and Hydroxyl Radical by 6-Hydroxydopamine, Dialuric Acid, and Related Cytotoxic Agents

1974 • 894 citations

Role of oxygen free radicals in carcinogenesis and brain ischemia

1990 • 885 citations

Role of Ca2+ in toxic cell killing

1989 • 856 citations

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1988 • 738 citations

Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease

1989 • 735 citations

Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation

1988 • 707 citations

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease

1989 • 621 citations

The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation.

1986 • 579 citations

Identification of the Iron-Responsive Element for the Translational Regulation of Human Ferritin mRNA

1987 • 547 citations

The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide.

1987 • 547 citations

Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis

1991 • 518 citations

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

1991 • 516 citations

Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation.

1987 • 474 citations

Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?

1989 • 471 citations

In vivo inhibition of superoxide dismutase in mice by diethyldithiocarbamate.

1976 • 457 citations

A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra

1989 • 445 citations

Brain iron and ferritin in Parkinson's and Alzheimer's diseases

1990 • 440 citations

Increased life expectancy resulting from addition of l-deprenyl to Madopar� treatment in Parkinson's disease: A longterm study

1985 • 437 citations

Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases.

1990 • 382 citations

The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil

1975 • 361 citations

The effect of age on the activity and molecular properties of human brain monoamine oxidase

1980 • 342 citations

Oxidative stress in mitochondria: Its relationship to cellular Ca2+ homeostasis, cell death, proliferation, and differentiation

1991 • 307 citations

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

1991 • 297 citations

Effects of the 21-aminosteroid U74006F on experimental head injury in mice

1988 • 296 citations

IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE

1977 • 293 citations

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

1989 • 290 citations

Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease

1991 • 285 citations

Neurochemical and Histochemical Characterization of Neurotoxic Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Brain Catecholamine Neurones in the Mouse

1985 • 281 citations

Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia Major

1985 • 272 citations

Peroxidative Changes in Brain Cortical Fatty Acids and Phospholipids, as Characterized During Fe2+‐ and Ascorbic Acid‐Stimulated Lipid Peroxidation In Vitro

1980 • 262 citations

Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

1986 • 258 citations

Oxygen Radicals and Tissue Injury

1997 • 257 citations

Decreased Ferritin Levels in Brain in Parkinson's Disease

1990 • 254 citations

Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism

1986 • 250 citations

Über den eisennachweis im gehirn, besonders in zentren des extrapyramidal-motorischen systems. I. Teil

1922 • 248 citations

Monoamine Oxidase Activity and Monoamine Metabolism in Brains of Parkinsonian Patients Treated with l‐Deprenyl

1986 • 243 citations

Mechanisms of cell death

1989 • 237 citations

Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior

1989 • 235 citations

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

1968 • 227 citations

Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels.

1988 • 214 citations

Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine and 1‐Methyl‐4‐Phenylpyridinium Ion on Activities of the Enzymes in the Electron Transport System in Mouse Brain

1987 • 214 citations

Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats

1991 • 194 citations

Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats

1988 • 176 citations

Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls.

1986 • 169 citations

Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: Behavioral and biochemical evidence

1989 • 160 citations

MPTP: A neurotoxin producing a parkinsonian syndrome

1987 • 146 citations

Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine. Potentiation by ascorbic acid.

1972 • 146 citations

Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity

1986 • 142 citations

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

1989 • 141 citations

Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F.

1988 • 139 citations

(-)-Deprenyl Leads to Prolongation of L-Dopa Efficacy in Parkinson�s Disease

2015 • 135 citations

The effect of melanin on iron associated decomposition of hydrogen peroxide

1988 • 132 citations

Brain Iron in the Rat: Extremely Slow Turnover in Normal Rats May Explain Long-Lasting Effects of Early Iron Deficiency

1977 • 131 citations

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate

1985 • 129 citations

Brain iron: a lesson from animal models

1989 • 128 citations

Nonidentical distribution of transferrin and ferric iron in human brain

1988 • 127 citations

Altered cellular distribution of iron in the central nervous system of myelin deficient rats

1990 • 126 citations

6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation

1989 • 121 citations

Mini Review: Smooth Muscle Pharmacology of Substance P

1982 • 117 citations

Long‐term consequence of early iron‐deficiency on dopaminergic neurotransmission in rats

1986 • 114 citations

Distribution of metal ions in the subcellular fractions of several rat brain areas

1976 • 112 citations

Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanol.

1976 • 110 citations

Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation.

1989 • 107 citations

On the mode of action of L-deprenyl in the human central nervous system

1978 • 104 citations

Iron in Brain Function and Dysfunction with Emphasis on Parkinson’s Disease

1991 • 103 citations

Brain iron : neurochemical and behavioural aspects

1988 • 103 citations

An autoradiographic study of the uptake and distribution of iron by the brain of the young rat

1990 • 98 citations

Original Papers: ON THE OCCURRENCE OF ABNORMAL DEPOSITS OF IRON IN THE BRAIN IN PARKINSONISM WITH SPECIAL REFERENCE TO ITS LOCALISATION.

1924 • 97 citations

Compensatory responses to nigrostriatal bundle injury

1989 • 95 citations

Ischemia, resuscitation, and reperfusion: Mechanisms of tissue injury and prospects for protection

1986 • 91 citations

Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier

1988 • 90 citations

Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity

1991 • 90 citations

Iron induces degeneration of nigrostriatal neurons

1992 • 89 citations

Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation

1988 • 89 citations

The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: Role of intracellular calcium

1988 • 87 citations

Paraquat toxicity is enhanced by iron and reduced by desferrioxamine in laboratory mice

1985 • 85 citations

Metal Ions in Neurology and Psychiatry

1986 • 84 citations

Energy-dependent accumulation of iron by isolated rat liver mitochondria. I. General features

1973 • 80 citations

Iron and ferritin in substantia nigra in Parkinson's disease.

1993 • 78 citations

N‐Methyl‐4‐phenylpyridine (MMP+ together with 6‐hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria

1986 • 72 citations

Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline)

1983 • 66 citations

Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice

1991 • 57 citations

Effects of 1‐Methyl‐4‐Phenyl‐1,2,5,6‐Tetrahydropyridine and Related Compounds on the Uptake of [3H]3,4‐Dihydroxyphenylethylamine and [3H]5‐Hydroxytryptamine in Neostriatal Synaptosomal Preparations

1985 • 51 citations

Biochemistry of the neurotoxic action of MPTP: or how a faulty batch of ‘designer drug’ led to parkinsonism in drug abusers

1987 • 49 citations

Hydroxyl Radicals and Biological Damagein vitro: What Relevancein vivo?

2008 • 45 citations

Metal ions in neurology and psychiatry

1985 • 44 citations

The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson’s disease

1990 • 44 citations

Selective Alteration in Blood‐Brain Barrier and Insulin Transport in Iron‐Deficient Rats

1988 • 43 citations

A Small Gibbon-Like Hominoid from the Miocene of Uganda

1975 • 38 citations

Attenuation of hemorrhagic shock by the non-glucocorticoid 21-aminosteroid U74006F

1988 • 37 citations

Oxidative damage to mitochondria and protection by ebselen and other antioxidants

1990 • 34 citations

Current status of iron chelation therapy with deferoxamine.

1990 • 32 citations

Dopaminforschung heute und morgen — L-Dopa in der Zukunft

1985 • 28 citations

The effect of a ferric iron complex on isolated rat-liver mitochondria. III. Mechanistic aspects of iron-induced calcium efflux

1987 • 25 citations

The neurotoxic component in Parkinson’s disease may involve iron-melanin interaction and lipid peroxidation in the substantia nigra

1990 • 12 citations

The effect of oxidative stress on levels of cytosolic calcium within and uptake of calcium by synaptosomes

1990 • 11 citations

Intraperitoneal deferoxamine therapy for iron overload in children undergoing CAPD

1989 • 11 citations

Deprenyl and the Progression of Parkinson's disease

1990 • 9 citations

Enzymatic synthesis of sarin and soman

1985 • 3 citations

Cited By (0)

No citing papers found in database

The possible role of iron in the etiopathology of parkinson's disease (1993) – Movement Disorders | Metascience Observatory Explorer